Latest Period
Q1 2026
Security Snapshot
BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) Institutional Ownership
CUSIP: 09075V102
13F Institutional Holders and Ownership History from Q4 2019 to Q1 2026
Institutions Reporting
269
Shares (Excl. Options)
47,396,853
Price
$88.88
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares)
- Symbol
- BNTX on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 47,396,853
- Total 13F value
- $4,209,915,104
- Portfolio coverage rank
- 0%
- Share change
- -620,637
- Value change
- -$68,924,940
- Number of holders
- 269
- Shares outstanding
- 253,647,595
- SEC-reported price per share
- $93.66
Latest holder snapshot
5 signals
Issuer context
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- BNTX - BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) is tracked under CUSIP 09075V102.
- 269 institutions reported positions in Q1 2026.
- 3 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 283 to 269 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $4,559,340,245 to $4,209,915,104.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 269 institutions filings for Q1 2026.
Security key
09075V102
Latest holder period
Q1 2026
13F holders
269
13D/G owners
3
CIK / CUSIP context first
Open Q1 2026 holders
BNTX full holder history
BioNTech SE SEC filings
BioNTech SE company facts
BioNTech SE insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 09075V102:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
3
Security
BNTX
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ATHOS KG | 40% | $9,712,577,099 | 101,702,378 | ATHOS KG | 31 Mar 2026 | |||
| Medine GmbH | 18% | $4,386,515,536 | 42,178,034 | Prof. Ugur Sahin, M.D. | 31 Mar 2025 | |||
| Sahin Ugur | 16% | $3,827,288,560 | 40,076,320 | Ugur Sahin | 31 Mar 2026 |
As of 31 Mar 2026, 269 institutional investors reported holding 47,396,853 shares of BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX). This represents 19% of the company’s total 253,647,595 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
15%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 2.3% | 5,856,073 | +31% | 0.36% | $520,488,000 |
| FMR LLC | 2.3% | 5,709,240 | -3.8% | 0.03% | $507,437,244 |
| PRIMECAP MANAGEMENT CO/CA/ | 1.5% | 3,793,711 | -0.17% | 0.27% | $337,185,032 |
| FLOSSBACH VON STORCH SE | 1.5% | 3,680,315 | -12% | 1.5% | $327,106,397 |
| Dodge & Cox | 1.4% | 3,676,791 | +1.7% | 0.18% | $326,793,184 |
| BlackRock, Inc. | 0.65% | 1,658,153 | +44% | 0% | $147,376,669 |
| BNP PARIBAS FINANCIAL MARKETS | 0.65% | 1,651,789 | 0% | 0.1% | $146,811,006 |
| Temasek Holdings (Private) Ltd | 0.59% | 1,506,027 | 0% | 0.45% | $133,855,680 |
| CITADEL ADVISORS LLC | 0.38% | 951,372 | +40% | 0.06% | $84,557,943 |
| BANK OF AMERICA CORP /DE/ | 0.36% | 903,029 | +23% | 0.01% | $80,261,218 |
| GSK plc | 0.35% | 889,824 | 0% | 13% | $79,087,557 |
| BAILLIE GIFFORD & CO | 0.35% | 882,572 | -29% | 0.08% | $78,442,999 |
| FIRST TRUST ADVISORS LP | 0.33% | 839,991 | +116% | 0.05% | $74,658,400 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 0.31% | 783,995 | +213% | 0.01% | $69,681,476 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 0.26% | 670,514 | 0.02% | $59,595,284 | |
| Long Focus Capital Management, LLC | 0.25% | 624,000 | +23% | 2.5% | $55,461,120 |
| Candriam S.C.A. | 0.19% | 488,367 | -19% | 0.23% | $43,406,059 |
| MORGAN STANLEY | 0.19% | 482,411 | -29% | 0% | $42,876,820 |
| DekaBank Deutsche Girozentrale | 0.19% | 481,397 | 0% | 0.07% | $42,055,000 |
| VICTORY CAPITAL MANAGEMENT INC | 0.19% | 476,923 | +19% | 0.03% | $42,388,916 |
| TANG CAPITAL MANAGEMENT LLC | 0.19% | 470,000 | 0% | 2.1% | $41,773,600 |
| DEUTSCHE BANK AG\ | 0.15% | 391,689 | -12% | 0.01% | $34,813,317 |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 0.15% | 387,214 | -3.3% | 0.03% | $34,381,961 |
| LBP AM SA | 0.15% | 385,109 | +4.5% | 0.47% | $34,228,488 |
| FRANKLIN RESOURCES INC | 0.15% | 384,626 | -33% | 0.01% | $34,185,531 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
26
Latest
Q1 2026
Rows shown
1-25 of 26
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 47,396,853 | $4,209,915,104 | -$68,924,940 | $88.88 | 269 |
| 2025 Q4 | 47,893,570 | $4,559,340,245 | -$440,516,031 | $95.20 | 283 |
| 2025 Q3 | 50,481,130 | $4,974,375,396 | -$319,748,638 | $98.62 | 253 |
| 2025 Q2 | 53,756,637 | $5,723,405,583 | +$241,986,249 | $106.47 | 255 |
| 2025 Q1 | 51,766,102 | $4,713,883,792 | +$16,375,983 | $91.06 | 276 |
| 2024 Q4 | 50,762,221 | $5,785,970,647 | +$270,315,091 | $113.95 | 299 |
| 2024 Q3 | 44,146,673 | $5,240,957,854 | +$448,042,220 | $118.77 | 288 |
| 2024 Q2 | 40,965,872 | $3,292,084,415 | -$3,371,001 | $80.36 | 278 |
| 2024 Q1 | 40,861,236 | $3,768,152,227 | +$21,661,779 | $92.25 | 278 |
| 2023 Q4 | 40,542,745 | $4,273,885,983 | +$369,420,974 | $105.54 | 277 |
| 2023 Q3 | 36,919,967 | $4,008,689,944 | -$40,677,233 | $108.64 | 245 |
| 2023 Q2 | 37,381,433 | $4,042,183,779 | -$207,319,966 | $107.93 | 246 |
| 2023 Q1 | 39,079,137 | $4,865,003,807 | -$130,605,071 | $124.57 | 272 |
| 2022 Q4 | 39,706,670 | $5,966,384,929 | +$387,882,980 | $150.22 | 312 |
| 2022 Q3 | 37,131,368 | $5,008,892,299 | +$489,942,648 | $134.88 | 249 |
| 2022 Q2 | 33,416,255 | $4,980,080,985 | -$212,346,370 | $149.10 | 276 |
| 2022 Q1 | 34,519,697 | $5,890,695,868 | -$225,320,254 | $170.56 | 274 |
| 2021 Q4 | 35,195,775 | $9,066,882,359 | -$433,429,701 | $257.80 | 334 |
| 2021 Q3 | 36,667,998 | $10,011,251,135 | +$781,975,407 | $272.99 | 328 |
| 2021 Q2 | 33,709,299 | $7,548,281,316 | +$1,380,454,495 | $223.88 | 275 |
| 2021 Q1 | 29,716,757 | $3,242,039,601 | +$922,839,812 | $109.19 | 213 |
| 2020 Q4 | 20,695,182 | $1,688,417,367 | -$282,174,671 | $81.52 | 183 |
| 2020 Q3 | 24,274,421 | $1,679,824,791 | -$160,429,955 | $69.23 | 144 |
| 2020 Q2 | 26,613,030 | $1,776,088,789 | +$1,335,873,540 | $66.74 | 108 |
| 2020 Q1 | 6,620,182 | $383,744,138 | -$108,916,451 | $58.40 | 36 |